Clinical Trial Update: Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of duvelisib with BMS-986345 in lymphoid malignancies, including non-Hodgkin lymphoma and Hodgkin lymphoma, has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphocytic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• BMS-986345 (BMS-986345)
• Duvelisib (duvelisib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non Hodgkin Lymphoma, Hodgkin Lymphoma | Phase 1 | Status: COMPLETED